PTCT FY 2021 Earnings — PTC Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PTCTPTC Therapeutics, Inc.

$6B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$539M+41.4% YoY

Gross Profit

$506M94.0% margin

Operating Income

-$374M-69.5% margin

Net Income

-$524M-97.3% margin

EPS (Diluted)

$-7.43

Cash Flow

Operating Cash Flow

-$251M

Free Cash Flow

-$337M

Stock-Based Comp.

$104M

Balance Sheet

Total Assets

$1.9B

Total Liabilities

$1.9B

Stockholders' Equity

$1M

Cash & Equivalents

$190M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$539M	$381M	+41.4%
Gross Profit	$506M	$362M	+39.9%
Operating Income	-$374M	-$432M	+13.3%
Net Income	-$524M	-$438M	-19.6%